SEC Filings | Allogene Therapeutics

Filing date	Description	Form	View
Aug 07, 2019	Report of unscheduled material events or corporate event	8-K	0001737287-19-000005.pdf 0001737287-19-000005.rtf 0001737287-19-000005.xls View HTML
Aug 07, 2019	Quarterly report which provides a continuing view of a company's financial position	10-Q	0001737287-19-000008.pdf 0001737287-19-000008.rtf 0001737287-19-000008.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
Jul 30, 2019	Statement of changes in beneficial ownership of securities	4	0001209191-19-043755.pdf 0001209191-19-043755.rtf View HTML
Jul 22, 2019	Statement of changes in beneficial ownership of securities	4	0001209191-19-042877.pdf 0001209191-19-042877.rtf View HTML
Jul 22, 2019	Statement of changes in beneficial ownership of securities	4	0001209191-19-042874.pdf 0001209191-19-042874.rtf View HTML
Jul 12, 2019	Statement of changes in beneficial ownership of securities	4	0001209191-19-041955.pdf 0001209191-19-041955.rtf View HTML
Jul 12, 2019	Statement of changes in beneficial ownership of securities	4	0001209191-19-041957.pdf 0001209191-19-041957.rtf View HTML
Jul 01, 2019	Statement of changes in beneficial ownership of securities	4	0001209191-19-039728.pdf 0001209191-19-039728.rtf View HTML
Jun 24, 2019	Statement of changes in beneficial ownership of securities	4	0001209191-19-038864.pdf 0001209191-19-038864.rtf View HTML
Jun 24, 2019	Statement of changes in beneficial ownership of securities	4	0001209191-19-038862.pdf 0001209191-19-038862.rtf View HTML

Data provided by Kaleidoscope.